ARGOS THERAPEUTICS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Revenue
Operating expenses
Research and development
General and administrative
Impairment loss on property and equipment
Restructuring costs
Gain on disposal of impaired property
Total operating expenses
Operating loss
Other income (expense)
Interest income
Interest expense
Gain on early extinguishment of debt
Change in fair value of warrant liability
Investment tax credits
Other (loss) income
Other income (expense), net
Net loss

Accretion of redeemable convertible preferred stock (See Note 19)
Net loss
Accretion of redeemable convertible preferred stock
Net loss attributable to common stockholders
Net loss attributable to common stockholders per share, basic and diluted (in dollars per share)
Weighted average shares outstanding, basic and diluted (in shares)

Comments